1. Home
  2. MLAB vs FPH Comparison

MLAB vs FPH Comparison

Compare MLAB & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • FPH
  • Stock Information
  • Founded
  • MLAB 1982
  • FPH 2009
  • Country
  • MLAB United States
  • FPH United States
  • Employees
  • MLAB N/A
  • FPH N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • FPH Real Estate
  • Sector
  • MLAB Industrials
  • FPH Finance
  • Exchange
  • MLAB Nasdaq
  • FPH Nasdaq
  • Market Cap
  • MLAB 341.1M
  • FPH 390.0M
  • IPO Year
  • MLAB N/A
  • FPH 2017
  • Fundamental
  • Price
  • MLAB $61.66
  • FPH $5.98
  • Analyst Decision
  • MLAB Buy
  • FPH
  • Analyst Count
  • MLAB 2
  • FPH 0
  • Target Price
  • MLAB $113.50
  • FPH N/A
  • AVG Volume (30 Days)
  • MLAB 118.5K
  • FPH 149.3K
  • Earning Date
  • MLAB 11-06-2025
  • FPH 10-16-2025
  • Dividend Yield
  • MLAB 1.04%
  • FPH N/A
  • EPS Growth
  • MLAB N/A
  • FPH 46.82
  • EPS
  • MLAB N/A
  • FPH 1.08
  • Revenue
  • MLAB $242,351,000.00
  • FPH $197,429,000.00
  • Revenue This Year
  • MLAB $5.38
  • FPH N/A
  • Revenue Next Year
  • MLAB $5.25
  • FPH N/A
  • P/E Ratio
  • MLAB N/A
  • FPH $5.54
  • Revenue Growth
  • MLAB 8.33
  • FPH N/A
  • 52 Week Low
  • MLAB $55.45
  • FPH $3.13
  • 52 Week High
  • MLAB $155.12
  • FPH $6.71
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 40.85
  • FPH 63.22
  • Support Level
  • MLAB $58.83
  • FPH $5.85
  • Resistance Level
  • MLAB $64.35
  • FPH $6.11
  • Average True Range (ATR)
  • MLAB 3.34
  • FPH 0.16
  • MACD
  • MLAB -0.03
  • FPH 0.05
  • Stochastic Oscillator
  • MLAB 19.78
  • FPH 78.33

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: